EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

A comparative exploration of immunohistochemical markers in patients with papulopustular rosacea undergoing treatment with oral isotretinoin versus doxycycline

Fabíola Picosse, Marco Alexandre Rocha iD, Caroline Sousa Costa, Milvia Maria Simões E Silva Enokihara, Adriana Sanudo, Ediléia Bagatin iD

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17420 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Fabíola Picosse und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Isotretinoin, Rosacea, Doxycycline, Dermatologic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rosacea is a chronic inflammatory disease, and doxycycline is a widely recommended treatment for it due to its anti‐inflammatory action. Oral isotretinoin reduces sebaceous gland activity and modulates toll‐like receptors, reducing inflammation. Our aim was to investigate the effect of these two drugs on the expression of cutaneous immunohistochemical biomarkers related to etiopathogenic factors involved in rosacea.

Methods

We conducted a randomized, comparative, and evaluator‐blinded trial, including 40 participants with moderate and severe papulopustular and ocular rosacea. Participants were treated with doxycycline (DOXY) 100 mg or isotretinoin (ISO) 0.3 mg/kg daily. Immunohistochemistry at baseline and after 4 months was used to demonstrate the expression of the biomarker on the affected skin.

Results

The following changes were detected: a reduction in the vessel count after using VEGF with DOXY ( P = 0.010); a decrease in VEGF intensity with ISO ( P < 0.001) and DOXY ( P = 0.020); a reduction of nitric oxide synthase enzyme with both drugs in the inflammatory infiltrate (ISO P < 0.001; DOXY P = 0.003); however, only with ISO was there a significant ( P = 0.030) decrease at the level of the sebaceous glands, indicating a reduction of nitric oxide synthesis; a reduction of TRPV‐1 expression at the level of the sebaceous glands was observed only with DOXY ( P = 0.041); a decrease of cathelicidin LL37 expression, a key antimicrobial peptide in the etiopathogenesis of rosacea, was noted with both drugs, although at the level of sebaceous glands, only with DOXY ( P = 0.007).

Conclusions

Oral isotretinoin and doxycycline have modified the expression of cutaneous biomarkers related to rosacea etiopathogenesis, demonstrating their role in controlling inflammatory and vascular processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinRosaceaDoxycyclineDermatologic AgentsHumansFemaleMaleAdultMiddle AgedAdministration, OralBiomarkersImmunohistochemistryVascular Endothelial Growth Factor ACathelicidinsSkinYoung AdultAgedTreatment Outcome

Stichwörter der Autor:innen

doxycyclineimmunohistochemistryisotretinoinrosaceatreatment

Substanzen

IsotretinoinDoxycyclineDermatologic AgentsBiomarkersVascular Endothelial Growth Factor ACathelicidinsVEGFA protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Discipline of Dermatology, Department of Specialized Medicine, Universidade Federal do Piauí, São Paulo, Brazil.
  • Department of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Department of Epidemiology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

ORCID-Profile: Marco Alexandre Rocha, Ediléia Bagatin

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Picosse, F., Rocha, M. A., Costa, C. S., Enokihara, M. M. S. E. S., Sanudo, A., & Bagatin, E. (2025). A comparative exploration of immunohistochemical markers in patients with papulopustular rosacea undergoing treatment with oral isotretinoin versus doxycycline. International Journal of Dermatology. https://doi.org/10.1111/ijd.17420

Vancouver

Picosse F, Rocha MA, Costa CS, Enokihara MMSES, Sanudo A, Bagatin E. A comparative exploration of immunohistochemical markers in patients with papulopustular rosacea undergoing treatment with oral isotretinoin versus doxycycline. International Journal of Dermatology. 2025. doi:10.1111/ijd.17420

BibTeX
@article{Picosse2025,
  author = {Picosse, Fabíola and Rocha, Marco Alexandre and Costa, Caroline Sousa and Enokihara, Milvia Maria Simões E Silva and Sanudo, Adriana and Bagatin, Ediléia},
  title = {A comparative exploration of immunohistochemical markers in patients with papulopustular rosacea undergoing treatment with oral isotretinoin versus doxycycline},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17420}
}
Kostenlos starten →